BARCLAYS PLC

Position in NVCR — NovoCure Ltd

CIK 312069 LONDON, X0

Back to NVCR Full portfolio

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,241,833

-$2,541,173 QoQ

Shares Held

297,416

-33.5% QoQ

Ownership

0.257%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Dec 31, 2024

CallValue

$894,000

CallShares

30,000

PutValue

$894,000

PutShares

30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $2,383,566,932 across 90 Medical Devices names. NVCR ranks #25 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MASI	Masimo Corp	2,743,985	$488,072,611
2	ABT	Abbott Laboratories	3,876,707	$398,021,505
3	SYK	Stryker Corp	1,027,154	$337,512,530
4	BSX	Boston Scientific Corp	5,024,157	$315,265,849
5	MDT	Medtronic plc	2,755,141	$238,732,965
6	GEHC	GE HealthCare Technologies Inc.	1,818,661	$129,452,288
7	EW	Edwards Lifesciences Corp	1,078,481	$86,364,757
8	BIO	Bio-Rad Laboratories, Inc.	278,835	$77,725,255

All Filings in NVCR

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,241,833	297,416	-33.5%	Shares	Defined	2026-05-15
2025-12-31	$5,783,006	447,255	+12.4%	Shares	Sole	2026-02-13
2025-09-30	$5,142,442	398,022	-3.9%	Shares	Defined	2026-03-31
2025-06-30	$7,374,379	414,291	+48.0%	Shares	Defined	2026-02-27
2025-03-31	$4,988,030	279,912	-39.2%	Shares	Sole	2026-03-17
2024-12-31	$13,709,638	460,055	+1433.5%	Shares	Sole	2026-03-19
2024-12-31	$894,000	30,000	0.0%	Put	Sole	2026-03-19
2024-12-31	$894,000	30,000	-93.4%	Call	Sole	2026-03-19
2024-09-30	$7,091,407	453,705	+40.8%	Shares	Defined	2026-03-31
2024-06-30	$5,521,271	322,316	+7.4%	Shares	Defined	2026-03-23
2024-03-31	$4,689,000	300,000	+27.4%	Call	Sole	2026-03-24
2024-03-31	$3,679,300	235,400	+123.1%	Shares	Sole	2026-03-24
2023-12-31	$1,575,620	105,534	+130.5%	Shares	Sole	2026-03-24
2023-09-30	$739,346	45,780	-44.5%	Shares	Defined	2026-03-26
2023-06-30	$3,425,907	82,552	-10.8%	Shares	Defined	2026-03-27
2023-03-31	$5,564,272	92,522	+18.8%	Shares	Sole	2026-03-30
2022-12-31	$5,712,936	77,886	+2.6%	Shares	Sole	2026-03-30
2022-09-30	$5,767,715	75,911	+7.4%	Shares	Sole	2022-11-03
2022-06-30	$4,910,313	70,652	+22.9%	Shares	Defined	2022-08-12
2022-03-31	$4,763,127	57,491	-15.0%	Shares	Sole	2022-05-16
2021-12-31	$5,077,058	67,622	+3459.1%	Shares	Sole	2022-02-23
2021-12-31	$142,652	1,900	-97.4%	Put	Sole	2022-02-23
2021-09-30	$8,403,736	72,340	+11956.7%	Shares	Defined	2021-11-09
2021-09-30	$69,702	600	-99.3%	Put	Sole	2021-11-09
2021-06-30	$18,234,489	82,204	+30.5%	Shares	Defined	2021-08-13
2021-03-31	$8,327,867	63,004	+56.1%	Shares	Sole	2021-05-13
2020-12-31	$6,983,546	40,358	+131.9%	Shares	Sole	2021-02-11
2020-12-31	$3,010,896	17,400	-30.1%	Put	Sole	2021-02-11
2020-12-31	$4,308,696	24,900	+110.9%	Call	Sole	2021-02-11
2020-09-30	$1,314,125	11,806	-32.1%	Shares	Sole	2020-11-12
2020-09-30	$1,936,794	17,400	-30.1%	Put	Sole	2020-11-12
2020-09-30	$2,771,619	24,900	+45.6%	Call	Sole	2020-11-12
2020-06-30	$1,014,030	17,100	-94.5%	Call	Sole	2020-08-12
2020-06-30	$18,573,647	313,215	+737.5%	Shares	Sole	2020-08-12
2020-06-30	$2,217,820	37,400	+118.7%	Put	Sole	2020-08-12
2020-03-31	$1,151,514	17,100	-74.6%	Call	Sole	2020-05-13
2020-03-31	$4,538,716	67,400	-83.9%	Put	Sole	2020-05-13
2020-03-31	$28,103,943	417,344	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.